Amgen (AMGN) Inventory (2009 - 2026)

Amgen has reported Inventory for 18 years, with the latest figure at $6.2 billion in Q2 2026.

• On a quarterly basis, Inventory fell 5.51% year-over-year to $6.2 billion in Q2 2026; TTM through Jun 2026 was $6.2 billion, a 5.51% decrease from a year earlier, with the FY2025 full-year figure at $6.2 billion, down 11.05% from the prior year.
• Inventory was $6.2 billion for Q2 2026 at Amgen, up from $6.2 billion in the prior quarter.
• The five-year high for Inventory was $9.5 billion in Q4 2023, with the low at $4.4 billion in Q1 2022.
• Average Inventory over 5 years is $6.3 billion, with a median of $6.2 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Inventory surged 93.06% in 2023, then fell 26.48% in 2024.
• Over 5 years, Inventory stood at $4.9 billion in 2022, then soared by 93.06% to $9.5 billion in 2023, then dropped by 26.48% to $7.0 billion in 2024, then slipped by 11.05% to $6.2 billion in 2025, then decreased by 0.08% to $6.2 billion in 2026.
• The last three Inventory figures came in at $6.2 billion (Q2 2026), $6.2 billion (Q1 2026), and $6.2 billion (Q4 2025), per Business Quant data.